Huntington National Bank’s Accretive Health AH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2 | Hold |
1
| – | – | ﹤0.01% | 4039 |
|
|
2025
Q4 | $2 | Hold |
1
| – | – | ﹤0.01% | 3952 |
|
|
2025
Q3 | $2 | Hold |
1
| – | – | ﹤0.01% | 3982 |
|
|
2025
Q2 | $2 | Hold |
1
| – | – | ﹤0.01% | 3988 |
|
|
2025
Q1 | $2 | Hold |
1
| – | – | ﹤0.01% | 3998 |
|
|
2024
Q4 | $2 | Hold |
1
| – | – | ﹤0.01% | 3997 |
|
|
2024
Q3 | $2 | Hold |
1
| – | – | ﹤0.01% | 3993 |
|
|
2024
Q2 | $2 | Hold |
1
| – | – | ﹤0.01% | 3938 |
|
|
2024
Q1 | $2 | Hold |
1
| – | – | ﹤0.01% | 3808 |
|
|
2023
Q4 | $2 | Hold |
1
| – | – | ﹤0.01% | 3711 |
|
|
2023
Q3 | $2 | Hold |
1
| – | – | ﹤0.01% | 3683 |
|
|
2023
Q2 | $2 | Hold |
1
| – | – | ﹤0.01% | 3627 |
|
|
2023
Q1 | $2 | Hold |
1
| – | – | ﹤0.01% | 3498 |
|
|
2022
Q4 | $2 | Hold |
1
| – | – | ﹤0.01% | 3365 |
|
|
2022
Q3 | $0 | Hold |
1
| – | – | ﹤0.01% | 2768 |
|
|
2022
Q2 | $0 | Hold |
1
| – | – | ﹤0.01% | 2771 |
|
|
2022
Q1 | $0 | Hold |
1
| – | – | ﹤0.01% | 2698 |
|
|
2021
Q4 | $0 | Hold |
1
| – | – | ﹤0.01% | 2624 |
|
|
2021
Q3 | $0 | Hold |
1
| – | – | ﹤0.01% | 2350 |
|
|
2021
Q2 | $0 | Hold |
1
| – | – | ﹤0.01% | 2239 |
|
|
2021
Q1 | $0 | Hold |
1
| – | – | ﹤0.01% | 2128 |
|
|
2020
Q4 | $0 | Hold |
1
| – | – | ﹤0.01% | 2106 |
|
|
2020
Q3 | $0 | Hold |
1
| – | – | ﹤0.01% | 2052 |
|
|
2020
Q2 | $0 | Hold |
1
| – | – | ﹤0.01% | 2065 |
|
|
2020
Q1 | $0 | Hold |
1
| – | – | ﹤0.01% | 2160 |
|
|
2019
Q4 | $0 | Hold |
1
| – | – | ﹤0.01% | 2172 |
|
|
2019
Q3 | $0 | Hold |
1
| – | – | ﹤0.01% | 2078 |
|
|
2019
Q2 | $0 | Buy |
+1
| New | – | ﹤0.01% | 2112 |
|
|
2019
Q1 | – | Sell |
-1
| Closed | – | – | 2106 |
|
|
2018
Q4 | $0 | Hold |
1
| – | – | ﹤0.01% | 2164 |
|
|
2018
Q3 | $0 | Buy |
+1
| New | – | ﹤0.01% | 2151 |
|
Huntington National Bank's AH Position: Q1 2026 in Review
Huntington National Bank held its Accretive Health (AH) position steady in Q1 2026 at 1 share worth $2. The position accounts for ﹤0.01% of the portfolio, ranked #4039.
Huntington National Bank first reported a position in AH in Q3 2018 and has held it in 30 quarters since. 1 fund tracked by Wall St. Rank holds AH as of Q1 2026.
- Huntington National Bank held 1 share of Accretive Health worth $2 as of Q1 2026.
- Huntington National Bank left its Accretive Health share count unchanged in Q1 2026.
- Accretive Health made up ﹤0.01% of Huntington National Bank's portfolio in Q1 2026, its #4039 holding.
- Huntington National Bank first reported a position in Accretive Health in Q3 2018 and has held it in 30 quarters since.
- 1 fund tracked by Wall St. Rank held Accretive Health as of Q1 2026.
Based on Huntington National Bank's 13F filing for Q1 2026, filed 15 May 2026.